Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This product is a **combination procedural medical kit** containing **lidocaine hydrochloride**, **triamcinolone acetonide**, and **isopropyl alcohol** as separate components packaged for office-based injections such as intra-articular and related musculoskeletal procedures. Lidocaine hydrochloride is a **small-molecule local anesthetic** that stabilizes neuronal membranes and inhibits voltage-gated sodium channel-mediated impulse conduction to provide local or regional anesthesia. Triamcinolone acetonide is a **small-molecule synthetic glucocorticoid corticosteroid** that activates the glucocorticoid receptor to suppress inflammatory signaling and reduce pain and swelling. Isopropyl alcohol serves as a **chemical disinfectant** for skin preparation and handling of multi-dose vials rather than as the principal therapeutic drug component. The kit is marketed under brands including LT and P-CARE K40MX and is used to facilitate corticosteroid injection procedures rather than representing a single co-formulated molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine hydrochloride + isopropyl alcohol + triamcinolone acetonide.